Abstract
Carriers of the mitochondrial mutation m.3243A>G presents highly variable phenotypes including mitochondrial encephalomyopathy, lactoacidosis and stroke-like episodes (MELAS). We conducted a follow-up study to evaluate changes in leucocyte heteroplasmy and the clinical phenotypes in m.3243A>G carriers. Leucocyte heteroplasmy was determined by next generation sequencing covered by 100 000X reads in 32 individuals with a median follow-up of 10.2 years. Ten-year clinical follow-up is reported in 46 individuals. The annual leucocyte mutation level declined by −0.7 (±0.4) percentage points/year (P <.0001), and correlated with the level of the initial sample (ρ = −0.92, P <.0001). Eleven of 46 m.3243A>G carriers died and clinical symptoms progressed. This longitudinal study shows the decline in leucocyte m.3243A>G heteroplasmy associates with the level of the initial sample. Further, there was a high mortality among carriers.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Clinical Genetics |
Vol/bind | 93 |
Udgave nummer | 4 |
Sider (fra-til) | 925-928 |
Antal sider | 4 |
ISSN | 0009-9163 |
DOI | |
Status | Udgivet - 2018 |